Matthew Pun

University of Michigan — United States

Medicine · Health Sciences

13h-index1.2kcitations158works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(112), Cancer, Hypoxia, and Metabolism(103), ATP Synthase and ATPases Research(79), Epigenetics and DNA Methylation(24), Ferrocene Chemistry and Applications(20)

Publications158 total

ZFTA–RELA ependymomas make itaconate to epigenetically drive fusion expression
Nature·2026· 1 citedOpen Access
Integration and Intersection of Cancer Metabolism with Epigenetic Pathways in Gliomas
Annual Review of Pathology Mechanisms of Disease·2025· 4 cited
Tamoxifen induces PI3K activation in uterine cancer
Nature Genetics·2025· 5 citedOpen Access
Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosis
Cancer Cell·2025· 11 cited
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Cancer Discovery·2025Open Access
Supplementary Figures 1-15 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025Open Access
Table S4 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025Open Access
Supplementary Data S2 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025Open Access
Table S2 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025Open Access
Table S11 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025Open Access
Table S16 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025Open Access
Table S13 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025Open Access
Table S1 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025Open Access
Table S3 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025Open Access
Table S8 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025Open Access
Table S6 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025Open Access
Table S5 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025Open Access
Table S14 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025Open Access
Table S15 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025Open Access
Supplementary Data S1 from Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
2025Open Access
page 1 of 8Next →

Frequent Co-authors

Sriram Venneti(28), Sunjong Ji(25), Stefan R. Sweha(25), Alexander R. Judkins(25), Carl Koschmann(25), Drew Pratt(24), Chan Chung(23), Andrea Franson(23), Fusheng Yang(23), Costas A. Lyssiotis(23), Mariella G. Filbin(23), Arul M. Chinnaiyan(23), Sebastian M. Waszak(22), Mateus Mota(22), Akash Deogharkar(22), Hugh Garton(22), Debra Hawes(22), Daniel Wahl(22), Li Jiang(22), Viveka Nand Yadav(22)